The Northwest Biotherapeutics (OTCMKTS:NWBO) stock has been in sharp focus among investors in recent weeks and has continued in the same vein this morning as it jumped by 5%.
That took the gains over the past week to 47%. The main trigger for the spike in the Northwest stock price came last week when the company announced that it had submitted the application to the Medicines and Healthcare Products Regulatory Agency (MHRA) with regards to the certification of its manufacturing plant in Sawston, United Kingdom.
It is a major milestone for the company since Northwest has worked on the preparation with regards to this application for around two years and a large part of those preparations took place last year at the height of the coronavirus pandemic. The entire package with regards to the momentous application was submitted by the company earlier on this month on May 7. It is going to be interesting to see if the Northwest stock can clock more gains this week.
Biotech, Tech, and Crypto reporter
Anthony Gonzales brings 3 years of experience in helping grassroots, mid-sized organizations and large institutions strengthen their management and resource generating capacities and effectively plan for the future. He is also a mentor and professional advisor to artists working in all disciplines. He is the gold medalist from St. Marco University of Science and Technology in the Bachelors of Financial Management as well.